Cite

HARVARD Citation

    You, S. et al. (2022). Discoidin Domain Receptor-Driven Gene Signatures as Markers of Patient Response to Anti–PD-L1 Immune Checkpoint Therapy. Journal of the National Cancer Institute. pp. 1380-1391. [Online]. 
  
Back to record